Richard Allan

Richard Allan is a Medical Writer at Laboratoires Théa since August 2018. Prior to this, Richard worked as a Chargé de Projet at ViroScan3D from September 2017 to July 2018. With a background in Biomedical Sciences, Richard has experience in managing molecular biology departments, implementing new technologies, and supervising projects. Richard's previous roles involved developing and implementing systems for genetic modification, constructing viral vectors, and analyzing gene expression in cancer cells. Richard's expertise spans from research assistant roles to project management in various scientific institutions.